Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Combined Modality Therapy"" wg kryterium: Temat


Tytuł:
Can adjuvant therapy restore or maintain the organ function after surgery?
Autorzy:
Chang WH; Department of Nursing, Taipei Veterans General Hospital, Taipei, Taiwan; Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan; Department of Obstetrics and Gynecology, Taipei Veterans General Hospital, Taipei, Taiwan.
Chou FW; Department of Obstetrics and Gynecology, Taipei Veterans General Hospital, Taipei, Taiwan.
Wang PH; Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan; Department of Obstetrics and Gynecology, Taipei Veterans General Hospital, Taipei, Taiwan; Female Cancer Foundation, Taipei, Taiwan; Department of Medical Research, China Medical University Hospital, Taichung, Taiwan. Electronic address: .
Pokaż więcej
Źródło:
Taiwanese journal of obstetrics & gynecology [Taiwan J Obstet Gynecol] 2023 Sep; Vol. 62 (5), pp. 630-631.
Typ publikacji:
Editorial
MeSH Terms:
Combined Modality Therapy*
Surgical Procedures, Operative*
Humans
Opinia redakcyjna
Tytuł:
Ultrasound-stimulated microbubbles enhanced vascular disruption in fractionated radiotherapy-treated tumours via ASMase activation.
Autorzy:
Leong KX; Physical Sciences, Sunnybrook Research Institute, Toronto, Ontario M4N 3M5, Canada.; Department of Radiation Oncology, Sunnybrook Health Sciences Centre, Toronto, Ontario M4N 3M5, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, Ontario M5G 1L7, Canada.; Department of Radiation Oncology, University of Toronto, Toronto, Ontario M5T 1P5, Canada.
Yang W; Physical Sciences, Sunnybrook Research Institute, Toronto, Ontario M4N 3M5, Canada.; Department of Radiation Oncology, Sunnybrook Health Sciences Centre, Toronto, Ontario M4N 3M5, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, Ontario M5G 1L7, Canada.; Department of Radiation Oncology, University of Toronto, Toronto, Ontario M5T 1P5, Canada.
Sharma D; Physical Sciences, Sunnybrook Research Institute, Toronto, Ontario M4N 3M5, Canada.; Department of Radiation Oncology, Sunnybrook Health Sciences Centre, Toronto, Ontario M4N 3M5, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, Ontario M5G 1L7, Canada.; Department of Radiation Oncology, University of Toronto, Toronto, Ontario M5T 1P5, Canada.
Liu S; Biological Sciences, Sunnybrook Research Institute, Toronto, Ontario M4N 3M5, Canada.; Department of Radiation Oncology, Sunnybrook Health Sciences Centre, Toronto, Ontario M4N 3M5, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, Ontario M5G 1L7, Canada.; Department of Radiation Oncology, University of Toronto, Toronto, Ontario M5T 1P5, Canada.
Czarnota GJ; Physical Sciences, Sunnybrook Research Institute, Toronto, Ontario M4N 3M5, Canada.; Department of Radiation Oncology, Sunnybrook Health Sciences Centre, Toronto, Ontario M4N 3M5, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, Ontario M5G 1L7, Canada.; Department of Radiation Oncology, University of Toronto, Toronto, Ontario M5T 1P5, Canada.
Pokaż więcej
Źródło:
Disease models & mechanisms [Dis Model Mech] 2023 Jun 01; Vol. 16 (6). Date of Electronic Publication: 2023 Jun 06.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Fibrosarcoma*/radiotherapy
Microbubbles*
Tumor Microenvironment*/radiation effects
Combined Modality Therapy*
Animals ; Mice ; Mice, Inbred C57BL ; Apoptosis ; Sphingomyelin Phosphodiesterase/metabolism ; Ultrasonics
Czasopismo naukowe
Tytuł:
Association between hospital safety-net burden and receipt of trimodality therapy and survival for patients with esophageal cancer.
Autorzy:
Qureshi MM; Department of Radiation Oncology, Boston Medical Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA.
Kam A; Department of Radiation Oncology, Boston Medical Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA.
Suzuki K; Department of Thoracic Surgery, Boston Medical Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA.
Litle V; Department of Thoracic Surgery, Boston Medical Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA.
Tapan U; Section of Hematology & Medical Oncology, Department of Medicine, Boston Medical Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA.
Balasubramaniyan R; Department of Radiation Oncology, Boston Medical Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA.
Dyer MA; Department of Radiation Oncology, Boston Medical Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA.
Truong MT; Department of Radiation Oncology, Boston Medical Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA.
Mak KS; Department of Radiation Oncology, Boston Medical Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA. Electronic address: .
Pokaż więcej
Źródło:
Surgery [Surgery] 2023 May; Vol. 173 (5), pp. 1153-1161. Date of Electronic Publication: 2023 Feb 10.
Typ publikacji:
Journal Article
MeSH Terms:
Esophageal Neoplasms*/therapy
Hospitals*
Combined Modality Therapy*
Female ; Humans ; Medicaid ; Medically Uninsured ; Proportional Hazards Models ; Safety-net Providers ; United States/epidemiology
Czasopismo naukowe
Tytuł:
Multimodal treatment with curative intent in a germline BRCA2 mutant metastatic ampullary adenocarcinoma: a case report.
Autorzy:
Mauri, Gianluca (AUTHOR)
Gori, Viviana (AUTHOR)
Patelli, Giorgio (AUTHOR)
Roazzi, Laura (AUTHOR)
Rizzetto, Francesco (AUTHOR)
De Carlis, Luciano (AUTHOR)
Mariani, Anna (AUTHOR)
Cavallari, Ugo (AUTHOR)
Prada, Elisabetta (AUTHOR)
Cipani, Tiziana (AUTHOR)
Aquilano, Maria Costanza (AUTHOR)
Bonoldi, Emanuela (AUTHOR)
Vanzulli, Angelo (AUTHOR)
Siena, Salvatore (AUTHOR)
Sartore-Bianchi, Andrea (AUTHOR)
Pokaż więcej
Źródło:
World Journal of Surgical Oncology. 10/13/2023, Vol. 21 Issue 1, p1-6. 6p.
Czasopismo naukowe
Tytuł:
Metal−Organic Frameworks Nucleated by Silk Fibroin and Modified with Tumor‐Targeting Peptides for Targeted Multimodal Cancer Therapy.
Autorzy:
Chen, Yuping (AUTHOR)
Lyu, Ruyin (AUTHOR)
Wang, Jie (AUTHOR)
Cheng, Qichao (AUTHOR)
Yu, Yanfang (AUTHOR)
Yang, Shuxu (AUTHOR)
Mao, Chuanbin (AUTHOR)
Yang, Mingying (AUTHOR)
Pokaż więcej
Źródło:
Advanced Science. Oct2023, Vol. 10 Issue 28, p1-13. 13p.
Czasopismo naukowe
Tytuł:
Multimodal intrathecal analgesia (MITA) with morphine for reducing postoperative opioid use and acute pain following hepato-pancreato-biliary surgery: A multicenter retrospective study.
Autorzy:
Ratnasekara, Vidhura (AUTHOR)
Weinberg, Laurence (AUTHOR)
Johnston, Samuel Anthony (AUTHOR)
Fletcher, Luke (AUTHOR)
Nugraha, Patrick (AUTHOR)
Cox, Daniel Robert Anthony (AUTHOR)
Hu, Raymond (AUTHOR)
Meyer, Ilonka (AUTHOR)
Yoshino, Osamu (AUTHOR)
Perini, Marcos Vinius (AUTHOR)
Muralidharan, Vijayaragavan (AUTHOR)
Nikfarjam, Mehrdad (AUTHOR)
Lee, Dong-Kyu (AUTHOR)
Pokaż więcej
Źródło:
PLoS ONE. 9/8/2023, Vol. 18 Issue 9, p1-19. 19p.
Czasopismo naukowe
Tytuł:
Leptomeningeal spread in high-grade gliomas: Is surgery or adjuvant therapy after leptomeningeal spread associated with survival benefit?
Autorzy:
Zhong S; Department of Neurosurgery, Sanbo Brain Hospital, Capital Medical University, Beijing, China.
Fu X; Department of Neurosurgery, Sanbo Brain Hospital, Capital Medical University, Beijing, China.
Wu C; Department of Neurosurgery, Sanbo Brain Hospital, Capital Medical University, Beijing, China.
Liu R; Department of Neurosurgery, Sanbo Brain Hospital, Capital Medical University, Beijing, China.
Li S; Department of Neurosurgery, Sanbo Brain Hospital, Capital Medical University, Beijing, China. .
Pokaż więcej
Źródło:
Neurosurgical review [Neurosurg Rev] 2023 Nov 23; Vol. 46 (1), pp. 311. Date of Electronic Publication: 2023 Nov 23.
Typ publikacji:
Journal Article
MeSH Terms:
Brain Neoplasms*/surgery
Brain Neoplasms*/drug therapy
Glioma*/surgery
Glioblastoma*
Humans ; Retrospective Studies ; Combined Modality Therapy
Czasopismo naukowe
Tytuł:
Improvement of the effectiveness of sonodynamic therapy: by optimizing components and combination with other treatments.
Autorzy:
Wang X; Zhuhai Institute of Translational Medicine, Department of Ultrasound and Department of Endocrinology and Metabolism, Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment, Zhuhai People's Hospital (Zhuhai Hospital Affiliated with Jinan University), The First School of Clinical Medicine of Guangdong Medical University, Zhuhai 519000, China. .
Xu X; Department of Ultrasound, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524001, China.
Yang Z; Zhuhai Institute of Translational Medicine, Department of Ultrasound and Department of Endocrinology and Metabolism, Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment, Zhuhai People's Hospital (Zhuhai Hospital Affiliated with Jinan University), The First School of Clinical Medicine of Guangdong Medical University, Zhuhai 519000, China. .
Xu X; Zhuhai Institute of Translational Medicine, Department of Ultrasound and Department of Endocrinology and Metabolism, Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment, Zhuhai People's Hospital (Zhuhai Hospital Affiliated with Jinan University), The First School of Clinical Medicine of Guangdong Medical University, Zhuhai 519000, China. .
Han S; Zhuhai Institute of Translational Medicine, Department of Ultrasound and Department of Endocrinology and Metabolism, Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment, Zhuhai People's Hospital (Zhuhai Hospital Affiliated with Jinan University), The First School of Clinical Medicine of Guangdong Medical University, Zhuhai 519000, China. .
Zhang H; Zhuhai Institute of Translational Medicine, Department of Ultrasound and Department of Endocrinology and Metabolism, Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment, Zhuhai People's Hospital (Zhuhai Hospital Affiliated with Jinan University), The First School of Clinical Medicine of Guangdong Medical University, Zhuhai 519000, China. .
Pokaż więcej
Źródło:
Biomaterials science [Biomater Sci] 2023 Nov 21; Vol. 11 (23), pp. 7489-7511. Date of Electronic Publication: 2023 Nov 21.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Ultrasonic Therapy*/methods
Neoplasms*/drug therapy
Photochemotherapy*/methods
Humans ; Combined Modality Therapy ; Reactive Oxygen Species/metabolism ; Cell Line, Tumor ; Tumor Microenvironment
Czasopismo naukowe
Tytuł:
Effects of cold atmospheric-pressure plasma in combination with doxorubicin drug against breast cancer cells in vitro and invivo.
Autorzy:
Dezhpour A; Department of Physics, Faculty of Science, University of Guilan, Rasht, Iran.
Ghafouri H; Department of Biology, Faculty of Science, University of Guilan, Rasht, Iran. Electronic address: .
Jafari S; Department of Physics, Faculty of Science, University of Guilan, Rasht, Iran. Electronic address: .
Nilkar M; Research Unit Plasma Technology (RUPT), Department of Applied Physics, Faculty of Engineering and Architecture, Ghent University, Sint-Pietersnieuwstraat 41 B4, 9000, Ghent, Belgium.
Pokaż więcej
Źródło:
Free radical biology & medicine [Free Radic Biol Med] 2023 Nov 20; Vol. 209 (Pt 2), pp. 202-210. Date of Electronic Publication: 2023 Oct 27.
Typ publikacji:
Journal Article
MeSH Terms:
Doxorubicin*/pharmacology
Neoplasms*
Animals ; Mice ; Reactive Oxygen Species ; bcl-2-Associated X Protein ; Combined Modality Therapy
Czasopismo naukowe
Tytuł:
IMbrave050: the first step towards adjuvant therapy in hepatocellular carcinoma.
Autorzy:
Vogel A; Toronto General Hospital, UHN, Toronto, ON M5G 2C4, Canada; Princess Margaret Cancer Centre, Toronto, ON, Canada; Hannover Medical School, Hannover, Germany. Electronic address: .
Meyer T; Royal Free Hospital, London, UK.
Saborowski A; Research Department of Oncology, UCL Cancer Institute, University College London, London, UK.
Pokaż więcej
Źródło:
Lancet (London, England) [Lancet] 2023 Nov 18; Vol. 402 (10415), pp. 1806-1807. Date of Electronic Publication: 2023 Oct 23.
Typ publikacji:
Journal Article; Comment
MeSH Terms:
Carcinoma, Hepatocellular*/drug therapy
Liver Neoplasms*/pathology
Humans ; Combined Modality Therapy ; Chemotherapy, Adjuvant ; Neoplasm Recurrence, Local
Czasopismo naukowe
Tytuł:
Proton therapy (PT) combined with concurrent chemotherapy for locally advanced non-small cell lung cancer with negative driver genes.
Autorzy:
Jin Y; Department of Radiotherapy, The Affiliated Hospital of Qingdao University, Qingdao, China.; School of Public Health, Qingdao University, Qingdao, China.
Shimizu S; Department of Radiation Oncology, University of Tsukuba Hospital, Tsukuba, Japan.; Department of Radiotherapy, YIZHOU Cancer Hospital, Qingdao, China.
Li Y; Department of Radiation Oncology, University of Tsukuba Hospital, Tsukuba, Japan.
Yao Y; Graduate School of Environmental Science, Hokkaido University, Sapporo, Hokkaido, Japan.
Liu X; Department of Radiotherapy, The Affiliated Hospital of Qingdao University, Qingdao, China.
Si H; School of Public Health, Qingdao University, Qingdao, China.
Sakurai H; Department of Radiation Oncology, University of Tsukuba Hospital, Tsukuba, Japan. .
Xiao W; Department of Radiotherapy, The Affiliated Hospital of Qingdao University, Qingdao, China. .
Pokaż więcej
Źródło:
Radiation oncology (London, England) [Radiat Oncol] 2023 Nov 16; Vol. 18 (1), pp. 189. Date of Electronic Publication: 2023 Nov 16.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*
Lung Neoplasms*
Proton Therapy*/adverse effects
Esophagitis*/etiology
Pneumonia*/complications
Pneumonia*/drug therapy
Humans ; Protons ; Retrospective Studies ; Chemoradiotherapy/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Combined Modality Therapy
Czasopismo naukowe
Tytuł:
Gastric cancer with peritoneal metastases: a single center outline and comparison of different surgical and intraperitoneal treatments.
Autorzy:
Santullo F; Surgical Unit of Peritoneum and Retroperitoneum, Fondazione Policlinico Universitario A. Gemelli IRCCS, Largo Agostino Gemelli 8, 00168, Rome, Italy.
Ferracci F; Surgical Unit of Peritoneum and Retroperitoneum, Fondazione Policlinico Universitario A. Gemelli IRCCS, Largo Agostino Gemelli 8, 00168, Rome, Italy. .
Abatini C; Surgical Unit of Peritoneum and Retroperitoneum, Fondazione Policlinico Universitario A. Gemelli IRCCS, Largo Agostino Gemelli 8, 00168, Rome, Italy.
Halabieh MAE; Surgical Unit of Peritoneum and Retroperitoneum, Fondazione Policlinico Universitario A. Gemelli IRCCS, Largo Agostino Gemelli 8, 00168, Rome, Italy.
Lodoli C; Surgical Unit of Peritoneum and Retroperitoneum, Fondazione Policlinico Universitario A. Gemelli IRCCS, Largo Agostino Gemelli 8, 00168, Rome, Italy.
D'Annibale G; Catholic University of the Sacred Heart, Rome, Italy.
Di Cesare L; Catholic University of the Sacred Heart, Rome, Italy.
D'Agostino L; Catholic University of the Sacred Heart, Rome, Italy.
Pecere S; Digestive Endoscopy Unit, Fondazione Policlinico A. Gemelli IRCCS, Largo Agostino Gemelli 8, 00168, Rome, Italy.
Di Giorgio A; Surgical Unit of Peritoneum and Retroperitoneum, Fondazione Policlinico Universitario A. Gemelli IRCCS, Largo Agostino Gemelli 8, 00168, Rome, Italy.
Strippoli A; Comprehensive Cancer Center, Fondazione Policlinico Universitario A. Gemelli IRCCS, Catholic University of the Sacred Heart, Largo A. Gemelli 8, Rome, Italy.
Pacelli F; Surgical Unit of Peritoneum and Retroperitoneum, Fondazione Policlinico Universitario A. Gemelli IRCCS, Largo Agostino Gemelli 8, 00168, Rome, Italy.
Pokaż więcej
Źródło:
Langenbeck's archives of surgery [Langenbecks Arch Surg] 2023 Nov 16; Vol. 408 (1), pp. 437. Date of Electronic Publication: 2023 Nov 16.
Typ publikacji:
Journal Article
MeSH Terms:
Stomach Neoplasms*/pathology
Peritoneal Neoplasms*/drug therapy
Hyperthermia, Induced*
Humans ; Combined Modality Therapy ; Retrospective Studies ; Chemotherapy, Cancer, Regional Perfusion ; Cytoreduction Surgical Procedures ; Postoperative Complications/therapy ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Survival Rate
Czasopismo naukowe
Tytuł:
Hollow Cu 2- x Se-based nanocatalysts for combined photothermal and chemodynamic therapy in the second near-infrared window.
Autorzy:
Gao Q; Ningbo Key Laboratory of Biomedical Imaging Probe Materials and Technology, Zhejiang International Cooperation Base of Biomedical Materials Technology and Application, Chinese Academy of Sciences (CAS) Key Laboratory of Magnetic Materials and Devices, Ningbo Cixi Institute of Biomedical Engineering, Zhejiang Engineering Research Center for Biomedical Materials, Ningbo Institute of Materials Technology and Engineering, Chinese Academy of Sciences, Ningbo, 315201, China.
He X; Ningbo Key Laboratory of Biomedical Imaging Probe Materials and Technology, Zhejiang International Cooperation Base of Biomedical Materials Technology and Application, Chinese Academy of Sciences (CAS) Key Laboratory of Magnetic Materials and Devices, Ningbo Cixi Institute of Biomedical Engineering, Zhejiang Engineering Research Center for Biomedical Materials, Ningbo Institute of Materials Technology and Engineering, Chinese Academy of Sciences, Ningbo, 315201, China.
He L; Ningbo Key Laboratory of Biomedical Imaging Probe Materials and Technology, Zhejiang International Cooperation Base of Biomedical Materials Technology and Application, Chinese Academy of Sciences (CAS) Key Laboratory of Magnetic Materials and Devices, Ningbo Cixi Institute of Biomedical Engineering, Zhejiang Engineering Research Center for Biomedical Materials, Ningbo Institute of Materials Technology and Engineering, Chinese Academy of Sciences, Ningbo, 315201, China.; Advanced Energy Science and Technology Guangdong Laboratory, Huizhou, 516000, China.
Lin J; Ningbo Key Laboratory of Biomedical Imaging Probe Materials and Technology, Zhejiang International Cooperation Base of Biomedical Materials Technology and Application, Chinese Academy of Sciences (CAS) Key Laboratory of Magnetic Materials and Devices, Ningbo Cixi Institute of Biomedical Engineering, Zhejiang Engineering Research Center for Biomedical Materials, Ningbo Institute of Materials Technology and Engineering, Chinese Academy of Sciences, Ningbo, 315201, China.; University of Chinese Academy of Sciences, Beijing 100049, P. R. China.; Advanced Energy Science and Technology Guangdong Laboratory, Huizhou, 516000, China.
Wang L; Ningbo Key Laboratory of Biomedical Imaging Probe Materials and Technology, Zhejiang International Cooperation Base of Biomedical Materials Technology and Application, Chinese Academy of Sciences (CAS) Key Laboratory of Magnetic Materials and Devices, Ningbo Cixi Institute of Biomedical Engineering, Zhejiang Engineering Research Center for Biomedical Materials, Ningbo Institute of Materials Technology and Engineering, Chinese Academy of Sciences, Ningbo, 315201, China.; Advanced Energy Science and Technology Guangdong Laboratory, Huizhou, 516000, China.
Xie Y; Ningbo Key Laboratory of Biomedical Imaging Probe Materials and Technology, Zhejiang International Cooperation Base of Biomedical Materials Technology and Application, Chinese Academy of Sciences (CAS) Key Laboratory of Magnetic Materials and Devices, Ningbo Cixi Institute of Biomedical Engineering, Zhejiang Engineering Research Center for Biomedical Materials, Ningbo Institute of Materials Technology and Engineering, Chinese Academy of Sciences, Ningbo, 315201, China.; Advanced Energy Science and Technology Guangdong Laboratory, Huizhou, 516000, China.
Wu A; Ningbo Key Laboratory of Biomedical Imaging Probe Materials and Technology, Zhejiang International Cooperation Base of Biomedical Materials Technology and Application, Chinese Academy of Sciences (CAS) Key Laboratory of Magnetic Materials and Devices, Ningbo Cixi Institute of Biomedical Engineering, Zhejiang Engineering Research Center for Biomedical Materials, Ningbo Institute of Materials Technology and Engineering, Chinese Academy of Sciences, Ningbo, 315201, China.; University of Chinese Academy of Sciences, Beijing 100049, P. R. China.; Advanced Energy Science and Technology Guangdong Laboratory, Huizhou, 516000, China.
Li J; Ningbo Key Laboratory of Biomedical Imaging Probe Materials and Technology, Zhejiang International Cooperation Base of Biomedical Materials Technology and Application, Chinese Academy of Sciences (CAS) Key Laboratory of Magnetic Materials and Devices, Ningbo Cixi Institute of Biomedical Engineering, Zhejiang Engineering Research Center for Biomedical Materials, Ningbo Institute of Materials Technology and Engineering, Chinese Academy of Sciences, Ningbo, 315201, China.; University of Chinese Academy of Sciences, Beijing 100049, P. R. China.; Advanced Energy Science and Technology Guangdong Laboratory, Huizhou, 516000, China.
Pokaż więcej
Źródło:
Nanoscale [Nanoscale] 2023 Nov 16; Vol. 15 (44), pp. 17987-17995. Date of Electronic Publication: 2023 Nov 16.
Typ publikacji:
Journal Article
MeSH Terms:
Nanoparticles*
Nanostructures*
Neoplasms*
Humans ; Combined Modality Therapy ; Autophagy ; Chloroquine ; Cell Line, Tumor
Czasopismo naukowe
Tytuł:
Photothermal nanozymes to self-augment combination cancer therapy by dual-glutathione depletion and hyperthermia/acidity-activated hydroxyl radical generation.
Autorzy:
Wang TH; Department of Chemical Engineering, National Chung Hsing University, Taichung 402, Taiwan.
Shen MY; Department of Chemical Engineering, National Chung Hsing University, Taichung 402, Taiwan.
Yeh NT; Department of Chemical Engineering, National Chung Hsing University, Taichung 402, Taiwan.
Chen YH; Department of Chemical Engineering, National Chung Hsing University, Taichung 402, Taiwan.
Hsu TC; Institute of Medicine, Chung Shan Medical University, Taichung 402, Taiwan; Immunology Research Center, Chung Shan Medical University, Taichung 402, Taiwan; Clinical Laboratory, Chung Shan Medical University Hospital, Taichung 402, Taiwan.
Chin HY; Institute of Medicine, Chung Shan Medical University, Taichung 402, Taiwan.
Wu YT; Institute of Medicine, Chung Shan Medical University, Taichung 402, Taiwan.
Tzang BS; Institute of Medicine, Chung Shan Medical University, Taichung 402, Taiwan; Immunology Research Center, Chung Shan Medical University, Taichung 402, Taiwan; Clinical Laboratory, Chung Shan Medical University Hospital, Taichung 402, Taiwan; Department of Biochemistry, School of Medicine, Chung Shan Medical University, Taichung 402, Taiwan. Electronic address: .
Chiang WH; Department of Chemical Engineering, National Chung Hsing University, Taichung 402, Taiwan. Electronic address: .
Pokaż więcej
Źródło:
Journal of colloid and interface science [J Colloid Interface Sci] 2023 Nov 15; Vol. 650 (Pt B), pp. 1698-1714. Date of Electronic Publication: 2023 Jul 22.
Typ publikacji:
Journal Article
MeSH Terms:
Chitosan*
Nanoparticles*
Neoplasms*/therapy
Humans ; Hydroxyl Radical ; Hydrogen Peroxide ; Combined Modality Therapy ; Glutathione ; Photothermal Therapy ; Cell Line, Tumor
Czasopismo naukowe
Tytuł:
Outcome of rare primary malignant bone sarcoma treated with multimodal therapy: Results from the EUROpean Bone Over 40 Sarcoma Study (EURO-B.O.S.S.).
Autorzy:
Palmerini E; Osteoncology, Bone and Soft Tissue Sarcomas, and Innovative Therapies, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.
Reichardt P; Sarcoma Center, Helios Klinikum Berlin-Buch, Berlin, Germany.
Hall KS; Department of Oncology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.
Bertulli R; Adult Mesenchymal Tumor Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
Bielack SS; Cooperative Osteosarcoma Study Group, Klinikum Stuttgart-Olgahospital, Stuttgart, Germany.
Comandone A; SC Oncologia Azienda Sanitaria Locale 'Città di Torino' Ospedale San Giovanni Bosco Torino, Turin, Italy.
Egerer G; University Hospital Heidelberg, Heidelberg, Germany.
Hansmeier A; Department of Hematology and Oncology, University Hospital Münster, Munster, Germany.
Kevric M; Cooperative Osteosarcoma Study Group, Klinikum Stuttgart-Olgahospital, Stuttgart, Germany.
Carretta E; Department of Programming and Monitoring, IRCCS Istituto Ortopedico RizzolI, Bologna, Italy.
Hansson L; Sahlgrenska University Hospital, Gothenburg, Sweden.
Jebsen N; Haukeland University Hospital, Bergen, Norway.
Eriksson M; Skåne University Hospital, Lund, Sweden.
Bruland ØS; Department of Oncology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Donati DM; Orthopedic Oncology, IRCCS Istituto Ortopedico RizzolI, Bologna, Italy.
Ibrahim T; Osteoncology, Bone and Soft Tissue Sarcomas, and Innovative Therapies, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.
Smeland S; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Division of Cancer Medicine and Scandinavian Sarcoma Group, Oslo University Hospital, Oslo, Norway.
Ferrari S; Osteoncology, Bone and Soft Tissue Sarcomas, and Innovative Therapies, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.
Pokaż więcej
Źródło:
Cancer [Cancer] 2023 Nov 15; Vol. 129 (22), pp. 3564-3573. Date of Electronic Publication: 2023 Aug 02.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Sarcoma*/pathology
Osteosarcoma*/drug therapy
Bone Neoplasms*/pathology
Leiomyosarcoma*/drug therapy
Male ; Humans ; Adult ; Middle Aged ; Aged ; Female ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Combined Modality Therapy ; Doxorubicin ; Ifosfamide
Czasopismo naukowe
Tytuł:
Current status and prospect of immunotherapy for colorectal cancer.
Autorzy:
Yang W; Department of Oncology, The First Affiliated Hospital of Wannan Medical College, Wuhu, China.
Zheng H; Department of Oncology, The First Affiliated Hospital of Wannan Medical College, Wuhu, China.
Lv W; Department of Oncology, The First Affiliated Hospital of Wannan Medical College, Wuhu, China.
Zhu Y; Department of Oncology, The First Affiliated Hospital of Wannan Medical College, Wuhu, China. .
Pokaż więcej
Źródło:
International journal of colorectal disease [Int J Colorectal Dis] 2023 Nov 14; Vol. 38 (1), pp. 266. Date of Electronic Publication: 2023 Nov 14.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Colonic Neoplasms*
Colorectal Neoplasms*/therapy
Humans ; Biomarkers ; Combined Modality Therapy ; Immunotherapy ; Neoadjuvant Therapy ; Molecular Targeted Therapy ; DNA Mismatch Repair
SCR Disease Name:
Turcot syndrome
Czasopismo naukowe
Tytuł:
Molecular insight into renal cancer and latest therapeutic approaches to tackle it: an updated review.
Autorzy:
Murali R; Department of Biomedical Sciences, School of Bio-Sciences and Technology, Vellore Institute of Technology VIT, Vellore, Tamil Nadu, 632014, India.
Gopalakrishnan AV; Department of Biomedical Sciences, School of Bio-Sciences and Technology, Vellore Institute of Technology VIT, Vellore, Tamil Nadu, 632014, India. .
Pokaż więcej
Źródło:
Medical oncology (Northwood, London, England) [Med Oncol] 2023 Nov 13; Vol. 40 (12), pp. 355. Date of Electronic Publication: 2023 Nov 13.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Carcinoma, Renal Cell*/genetics
Carcinoma, Renal Cell*/therapy
Kidney Neoplasms*/genetics
Kidney Neoplasms*/therapy
Humans ; Immunotherapy ; Combined Modality Therapy ; Carcinogenesis
Czasopismo naukowe
Tytuł:
Initial management and survival of patients with primary metastatic bladder cancer before the immunotherapy era: a population-based study from Norway.
Autorzy:
Møller CT; Department of Research, Cancer Registry of Norway, Oslo, Norway; Faculty of Medicine, University of Oslo, Oslo, Norway. .
Tafjord G; Department of Oncology, Oslo University Hospital, Oslo, Norway.
Blindheim A; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway; Department of Surgery, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.
Berge V; Faculty of Medicine, University of Oslo, Oslo, Norway; Department of Urology, Oslo University Hospital, Oslo, Norway.
Fosså S; Faculty of Medicine, University of Oslo, Oslo, Norway; National Advisory Unit on Late Effects after Cancer Treatment, Oslo University Hospital, Oslo, Norway.
Andreassen BK; Department of Research, Cancer Registry of Norway, Oslo, Norway.
Pokaż więcej
Źródło:
Scandinavian journal of urology [Scand J Urol] 2023 Nov 10; Vol. 58, pp. 101-108. Date of Electronic Publication: 2023 Nov 10.
Typ publikacji:
Journal Article
MeSH Terms:
Urinary Bladder Neoplasms*/mortality
Urinary Bladder Neoplasms*/pathology
Urinary Bladder Neoplasms*/therapy
Humans ; Combined Modality Therapy ; Cystectomy/methods ; Immunotherapy ; Norway ; Neoplasm Metastasis
Czasopismo naukowe
Tytuł:
First clinical application of image-guided intraoperative electron radiation therapy with real time intraoperative dose calculation in recurrent rectal cancer: technical procedure.
Autorzy:
Roeder F; Department of Radiation Therapy and Radiation Oncology, Paracelsus Medical University, Müllner Hauptstrasse 48, 5020, Salzburg, Austria. .
Fastner G; Department of Radiation Therapy and Radiation Oncology, Paracelsus Medical University, Müllner Hauptstrasse 48, 5020, Salzburg, Austria.
Fussl C; Department of Radiation Therapy and Radiation Oncology, Paracelsus Medical University, Müllner Hauptstrasse 48, 5020, Salzburg, Austria.
Sedlmayer F; Department of Radiation Therapy and Radiation Oncology, Paracelsus Medical University, Müllner Hauptstrasse 48, 5020, Salzburg, Austria.; Institute of Research and Development of Advanced Radiation Technologies (radART), Paracelsus Medical University, Müllner Hauptstrasse 48, Salzburg, Austria.
Stana M; Department of Radiation Therapy and Radiation Oncology, Paracelsus Medical University, Müllner Hauptstrasse 48, 5020, Salzburg, Austria.
Berchtold J; Department of Radiation Therapy and Radiation Oncology, Paracelsus Medical University, Müllner Hauptstrasse 48, 5020, Salzburg, Austria.
Jäger T; Department of Visceral and Thoracic Surgery, Paracelsus Medical University, Müllner Hauptstrasse 48, Salzburg, Austria.
Presl J; Department of Visceral and Thoracic Surgery, Paracelsus Medical University, Müllner Hauptstrasse 48, Salzburg, Austria.
Schredl P; Department of Visceral and Thoracic Surgery, Paracelsus Medical University, Müllner Hauptstrasse 48, Salzburg, Austria.
Emmanuel K; Department of Visceral and Thoracic Surgery, Paracelsus Medical University, Müllner Hauptstrasse 48, Salzburg, Austria.
Colleselli D; Department of Urology, Paracelsus Medical University, Müllner Hauptstrasse 48, Salzburg, Austria.
Kotolacsi G; Department of Anesthesiology, Paracelsus Medical University, Müllner Hauptstrasse 48, Salzburg, Austria.
Scherer P; Department of Radiation Therapy and Radiation Oncology, Paracelsus Medical University, Müllner Hauptstrasse 48, 5020, Salzburg, Austria.
Steininger P; Institute of Research and Development of Advanced Radiation Technologies (radART), Paracelsus Medical University, Müllner Hauptstrasse 48, Salzburg, Austria.
Gaisberger C; Department of Radiation Therapy and Radiation Oncology, Paracelsus Medical University, Müllner Hauptstrasse 48, 5020, Salzburg, Austria.; Institute of Research and Development of Advanced Radiation Technologies (radART), Paracelsus Medical University, Müllner Hauptstrasse 48, Salzburg, Austria.
Pokaż więcej
Źródło:
Radiation oncology (London, England) [Radiat Oncol] 2023 Nov 10; Vol. 18 (1), pp. 186. Date of Electronic Publication: 2023 Nov 10.
Typ publikacji:
Journal Article
MeSH Terms:
Radiotherapy, Image-Guided*/methods
Rectal Neoplasms*/diagnostic imaging
Rectal Neoplasms*/radiotherapy
Rectal Neoplasms*/surgery
Humans ; Electrons ; Combined Modality Therapy ; Cone-Beam Computed Tomography ; Intraoperative Period ; Intraoperative Care
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies